Morgan Stanley Ensysce Biosciences, Inc. Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.05 - $153.6 $13 - $41,011	-267 Reduced 98.89%	3 $0
Q1 2022 May 13, 2022	SELL	$230.4 - $1140.0 $8,985 - $44,460	-39 Reduced 12.62%	270 $0
Q4 2021 Feb 14, 2022	SELL	$300.0 - $1228.8 $888,000 - $3.64 Million	-2,960 Reduced 90.55%	309 $1,000
Q3 2021 Nov 15, 2021	BUY	$696.0 - $3477.6 $2.28 Million - $11.4 Million	3,269 New	3,269 $10,000

100

Ticker ENSC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,918,900
Market Cap $1.25M
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.